Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation鸟苷酸环化酶的新型增强剂-通过变构调节起作用的活性BRITISH JOURNAL OF PHARMACOLOGYIF7.72023-08-291OA
Effects of AAV9-mediated cardiac phosphodiesterase 4B and 2A overexpression in a mouse model of heart failure with preserved ejection fractionJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72022-12-010PRE
The influence of cytohesin inhibitor SecinH3 on natriuretic peptide signalling in cardiomyocytesJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72022-12-010PRE
CNP regulates cardiac contractility and increases cGMP near both SERCA and TnI: difference from BNP visualized by targeted cGMP biosensorsCARDIOVASCULAR RESEARCHIF13.32021-05-1014OAAI
FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neuronsCOMMUNICATIONS BIOLOGYIF5.12019-10-2934OAAI
Knockout of adenylyl cyclase isoform 5 or 6 differentially modifies the β1-adrenoceptor-mediated inotropic responseJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72019-06-018OAAI
Characterization of early cardiotoxicity action of calcineurin inhibitorsJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72018-07-010PREAI
PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing heartsEUROPEAN JOURNAL OF PHARMACOLOGYIF4.72017-10-0128PREAI
Different Compartmentation of Responses to Brain Natriuretic Peptide and C-Type Natriuretic Peptide in Failing Rat VentricleJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICSIF3.82014-09-0129PREAI
Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardiumNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYIF3.12014-01-1521PREAI
Acidic biphenyl derivatives: Synthesis and biological activity of a new series of potent 5-HT4 receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32013-11-0111PRE
SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardiumBRITISH JOURNAL OF PHARMACOLOGYIF7.72013-08-2725OAAI
Synthesis and pharmacological properties of a new hydrophilic and orally bioavailable 5-HT4 antagonistEUROPEAN JOURNAL OF MEDICINAL CHEMISTRYIF5.92013-06-018PREAI
Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricleNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGYIF3.12011-09-0823OAAI
Novel Benzo[b]thiophene Derivatives as New Potential Antidepressants with Rapid Onset of ActionJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-04-0697OAAI
Differential regulation of β2-adrenoceptor-mediated inotropic and lusitropic response by PDE3 and PDE4 in failing and non-failing rat cardiac ventricleBRITISH JOURNAL OF PHARMACOLOGYIF7.72010-12-0618OAAI
Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonistsBIOORGANIC & MEDICINAL CHEMISTRYIF32010-12-0117PREAI
EBV infection renders B cells resistant to growth inhibition via adenylyl cyclaseCELLULAR SIGNALLINGIF3.72008-06-018PREAI
5-HT4-mediated positive inotropic effect is regulated by phosphodiesterase 3 in failing rat heart and human ventricleJOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72007-06-010PREAI
The 5-HT4 receptor -: a foetal gene reactivated in heart failure?JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYIF4.72006-06-011PREAI